All In Biotech

Drug Trial Radar · NCT01080391

Study Comparing Carfilzomib, Lenalidomide, and Dexamethasone (CRd) vs Lenalidomide and Dexamethasone (Rd) in Subjects With Relapsed Multiple Myeloma

A Randomized, Multicenter, Phase 3 Study Comparing Carfilzomib, Lenalidomide, and Dexamethasone (CRd) vs Lenalidomide and Dexamethasone (Rd) in Subjects With Relapsed Multiple Myeloma

Last checked: Nov 20, 2026Latest source record: Sep 21, 2022 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. Randomized with 792 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

792

Actual

Start

Jul 14, 2010

Primary completion

Jun 16, 2014

Study completion Dec 5, 2017

Sponsor

Lead sponsor
AmgenAmgen (AMGN)
Sponsor type
Industry
First posted
Mar 4, 2010

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The primary objective was to compare progression-free survival in adults with relapsed multiple myeloma who are receiving CRd vs participants receiving Rd in a randomized multicenter setting.

Conditions

  • Relapsed Multiple Myeloma

Interventions

  • DexamethasoneDrug

    40 mg orally or IV on days 1, 8, 15, 22

  • LenalidomideDrug

    25 mg orally on days 1-21

  • CarfilzomibDrug

    20 mg/m², 27 mg/m² intravenously

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Progression-free Survival (PFS)Time frame: From randomization through the data cutoff date of 16 June 2014. Median follow-up time was approximately 31 months.

Locations

127 sites in 20 countries. Site status is shown where the registry gives one.

  • Mayo Clinic

    Scottsdale, Arizona

  • Providence St. Joseph Medical Center

    Burbank, California

  • St. Jude Hospital Yorba Linda dba; St. Joseph Heritage Healthcare

    Santa Rosa, California

  • Stanford University

    Stanford, California

  • Colorado Blood Cancer Institute

    Denver, Colorado

  • Cancer and Blood Disease Center

    Lecanto, Florida

  • Rush University Medical Center

    Chicago, Illinois

  • Indiana University Health Melvin and Bren Simon Cancer Center

    Indianapolis, Indiana

  • University of Kansas Cancer Center

    Kansas City, Kansas

  • The University of Michigan - Comprehensive Cancer Center

    Ann Arbor, Michigan

  • Mayo Clinic

    Rochester, Minnesota

  • John Theurer Cancer Center at Hackensack University Medical Center

    Hackensack, New Jersey

  • NYU Clinical Cancer Center

    New York, New York

  • Weill Cornell Medical College

    New York, New York

  • Associates in Oncology and Hematology

    Chattanooga, Tennessee

  • The Don & Sybil Harrington Cancer Center

    Amarillo, Texas

  • Baylor Sammons Cancer Center

    Dallas, Texas

  • UT Southwestern Medical Center at Dallas

    Dallas, Texas

  • The University of Texas, MD Anderson Cancer Center

    Houston, Texas

  • Scott and White Memorial Hospital

    Temple, Texas

  • Fred Hutchinson Cancer Research Center

    Seattle, Washington

  • Froedtert & Medical College of Wisconsin

    Milwaukee, Wisconsin

  • Medizinische Universitat Wien

    Vienna, Austria

  • Wilhelminspital der Stadt Wien, Zentrum fur Onkologie und Hamatologie

    Vienna, Austria

  • Ziekenhuisnetwerk Antwerpen - AZ Stuivenberg

    Antwerp, Belgium

  • AZ Sint-Jan AV

    Bruges, Belgium

  • Institut Jules Bordet

    Brussels, Belgium

  • UZ Brussel

    Brussels, Belgium

  • Cliniques Universitaires Saint-Luc

    Brussels, Belgium

  • UZ Leuven

    Leuven, Belgium

  • University Multiprofile Hospital for Active Treatment, "Dr. Georgi Stranski"

    Pleven, Bulgaria

  • University Multiprofile Hospital for Active Treatment "Sveti Georgi"

    Plovdiv, Bulgaria

  • Military Medical Academy Multiprofile Hospital for Active Treatment

    Sofia, Bulgaria

  • Specialized Hospital for Active Treatment of Hematological Diseases

    Sofia, Bulgaria

  • Multiprofile Hospital for Active Treatment "Sveta Marina"

    Varna, Bulgaria

  • Tom Baker Cancer Centre

    Calgary, Alberta, Canada

  • University of Alberta, Cross Cancer Institute

    Edmonton, Alberta, Canada

  • Vancouver General Hospital

    Vancouver, British Columbia, Canada

  • Cancer Care Manitoba

    Winnipeg, Manitoba, Canada

  • General Hospital, Health Sciences Centre

    St. John's, Newfoundland and Labrador, Canada

Showing 40 of 127 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.